GeneNeer
PrivateLast Round
Seed
Jan 9, 2024
Total Funding Raised
$2.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GeneNeer operates in Healthcare & Life Sciences and is based in Shoham. Its latest recorded funding round was a Seed round in January 2024.
GeneNeer is an agritech company that develops gene-editing platforms for smart and fast crop breeding to address the impacts of climate change.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneNeer Comparables
Compare GeneNeer with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hudson River Biotechnology | 84% | |
| Phytoform Labs | 84% | |
| Spearhead Bio | 79% |
For institutional investors. Book with your work email.
GeneNeer Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GeneNeer Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tall Grass Ventures | Seed |
| 2b AHEAD Ventures | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 3092% MoM, reaching 3.1K.
- May 14, 2025
Gusui Wu joins as Senior Scientific Advisor.
For institutional investors. Book with your work email.
GeneNeer Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneNeer's valuation, stock price, and market status.
Is GeneNeer a public or private company?
GeneNeer is a private company.
What is the current stock price of GeneNeer?
GeneNeer is a private company, so its shares have no public market price. Caplight tracks GeneNeer's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneNeer worth (valuation)?
Valuation information for GeneNeer is not publicly available.
Can I buy GeneNeer stock?
GeneNeer shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneNeer's last funding round?
GeneNeer's most recent funding round was Seed on January 9, 2024.
Who are the main investors in GeneNeer?
Key investors in GeneNeer include Tall Grass Ventures, 2b AHEAD Ventures.
Will GeneNeer IPO soon?
No public IPO plans have been announced for GeneNeer.
How can I track GeneNeer secondary market activity?
Caplight tracks bids, offers, and trades in GeneNeer's shares on secondary markets.